Tag

Glp 1 Medication

All articles tagged with #glp 1 medication

health2 years ago•4 min saved

"Understanding the Personality Changes Linked to Ozempic Use"

The use of Ozempic and similar GLP-1 medications, originally intended for diabetes treatment, is reportedly causing changes in personality and behavior in some patients, including anxiety, depression, and reduced cravings for drugs and alcohol. Experts believe these drugs impact dopamine levels, affecting emotional and physical drive for food as well as feelings of reward, pleasure, motivation, and movement. While the FDA has received reports of psychiatric disorders connected to these medications, the long-term effects and potential misuse for weight loss are still being studied.

via New York Post |

#dopamine #glp-1-medication #health

health-and-wellness2 years ago•5 min saved

"Survey Finds Increased Caloric Intake After Discontinuing Weight Loss Medication"

A Deutsche Bank survey found that calorie consumption declines when patients take GLP-1 medications like Novo Nordisk's Ozempic or Wegovy, but once the medication is stopped, calorie intake rises again, sometimes even surpassing pre-treatment levels. The survey also revealed that interest in weight loss programs may be peaking, which could be a good time for investors to hold food and beverage stocks. Additionally, the survey results align with the understanding that appetite can return strongly after stopping GLP-1 therapy, highlighting the long-term implications of anti-obesity medications on the food and beverage industry.

via CNBC|

#food-and-beverage-industry #glp-1-medication #health-and-wellness

healthcare2 years ago•5 min saved

Eli Lilly's Journey: From Alzheimer's Breakthrough to Drug Launches

Eli Lilly's chief scientific and medical officer, Dr. Daniel Skovronsky, expressed optimism about the company's experimental treatment for Alzheimer's disease, which is currently undergoing clinical trials. In addition, Skovronsky discussed the potential of less expensive weight-loss drugs and the success of Lilly's Mounjaro treatment for Type 2 diabetes, a GLP-1 medication that has contributed to the company's stock soaring 63% this year.

via MarketWatch|

#alzheimers-disease #clinical-trials #eli-lilly